1Deshpande A, Mina E, Glahe C, et al. Different conformation of amyloid beta induce neurotoxicity by distinct mechanism in human cortical neuron[J]. J Neurosci,2006 ;26 (22) :6011-8.
2Viola KL,Velaseo PT,Klein WL. Why Alzheimer' is a disease of memory : the attack on synapses by A beta oligomens ( ADDLs ) [J]. J Nutr Heath Aging,2008 ;12( 1 ) 51-7.
3Dhitavat S, Ortize D, Rogers E, et al. Folate, vitamin E, and acetyl-L- camitine provide synergistic protection against oxidative stree resulting from exposure of human neuroblastoma cells to amyloid beta [J]. Brain Res, 2005 ; 1061 ( 2 ) : 114-7.
4Ding H, Mathews TA, Johnson GVW. Site-specific phosphorylation and easpase cleavage differentially impact tau-microtubule interractions and tau aggregation[J]. J Bio Chem ,2006 ;281 (28) : 19107-14.
5Chong YH, Shin YJ, Lee EO,et al. ERK1/2 activation mediates A beta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in at organotypic hippocampal slice cultures[J]. J Bio Chem, 2006 ; 281 (29) :20315-25.
6Solomon B. Immunological approaches for amyloid-beta clearance toward treatment for Alzheimer' s disease [J].Rejuvenation Res, 2008 ; 11 ( 2 ) : 349-57.
7Pardridge WM,Vinters HV, Yang J,et al. Amyloid angiopathy of Alzheimer's disease: amino acid composition and partial sequence of a 4 200- dalton peptide isolated from cortical microvessels [J].J Neurochem, 1987 ;49(5 ) : 1394-401.
8Yamada M, Tsukagoshi, Otomo E, et al. Systemic amyloid deposition in old age and dementia of Alzheimer type:the relationship of brain amyloid to other amyloid[J]. Acta Neuropathol, 1988 ;77 (2) :136-41.
9Schenk D, Barbour R, Dunn W,et al. Immunization with amyloid-beta attenuate Alzheimer's disease-like pathology in the PDAPP mouse [J]. Nature, 1999 ;400 ( 6740 ) : 173-7.
10Janus C, Pearson J, Melaurin J,et al. A beta peptide immunization reduces behavioural impairment and plaques in a modle of Alzheimer's disease[J]. Nature,2000;408(6815):979-82.
